Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia.
Lee SH, Cho KI, Kim JY, Ahn YK, Rha SW, Kim YJ, Choi YS, Choi SW, Jeon DW, Min PK, Choi DJ, Baek SH, Kim KS, Byun YS, Jang Y.
Atherosclerosis. 2012 Mar;221(1):169-75. Epub 2012 Jan 5.
Related citations
The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: study with artificial emulsions.
Carneiro MM, Miname MH, Gagliardi AC, Pereira C, Pereira AC, Krieger JE, Maranhão RC, Santos RD.
Atherosclerosis. 2012 Mar;221(1):268-74. Epub 2011 Dec 29.
Molecular characterization of familial hypercholesterolemia in Spain.
Palacios L, Grandoso L, Cuevas N, Olano-Martín E, Martinez A, Tejedor D, Stef M.
Atherosclerosis. 2012 Mar;221(1):137-42. Epub 2011 Dec 23.
Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice.
Fuster JJ, Molina-Sánchez P, Jovaní D, Vinué Á, Serrano M, Andrés V.
Atherosclerosis. 2012 Mar;221(1):98-105. Epub 2011 Dec 17.
Deficiency of receptor-associated protein attenuates angiotensin II-induced atherosclerosis in hypercholesterolemic mice without influencing abdominal aortic aneurysms.
Wang S, Subramanian V, Lu H, Howatt DA, Moorleghen JJ, Charnigo R, Cassis LA, Daugherty A.
Atherosclerosis. 2012 Feb;220(2):375-80. Epub 2011 Nov 19.
Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia.
Koh KK, Quon MJ, Shin KC, Lim S, Lee Y, Sakuma I, Lee K, Han SH, Shin EK.
Atherosclerosis. 2012 Feb;220(2):537-44. Epub 2011 Nov 19.
The Arabic allele: a single base pair substitution activates a 10-base downstream cryptic splice acceptor site in exon 12 of LDLR and severely decreases LDLR expression in two unrelated Arab families with familial hypercholesterolemia.
Shawar SM, Al-Drees MA, Ramadan AR, Ali NH, Alfadhli SM.
Atherosclerosis. 2012 Feb;220(2):429-36. Epub 2011 Nov 9.
Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE-/- mice.
Cesena FH, Dimayuga PC, Yano J, Zhao X, Kirzner J, Zhou J, Chan LF, Lio WM, Cercek B, Shah PK, Chyu KY.
Atherosclerosis. 2012 Jan;220(1):59-65. Epub 2011 Oct 12.
Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia.
Neefjes LA, Ten Kate GJ, Alexia R, Nieman K, Galema-Boers AJ, Langendonk JG, Weustink AC, Mollet NR, Sijbrands EJ, Krestin GP, de Feyter PJ.
Atherosclerosis. 2011 Dec;219(2):721-7. Epub 2011 Oct 8.
Resequencing the apolipoprotein A5 (APOA5) gene in patients with various forms of hypertriglyceridemia.
Evans D, Aberle J, Beil FU.
Atherosclerosis. 2011 Dec;219(2):715-20. Epub 2011 Sep 24.
Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortality.
Versmissen J, Botden IP, Huijgen R, Oosterveer DM, Defesche JC, Heil TC, Muntz A, Langendonk JG, Schinkel AF, Kastelein JJ, Sijbrands EJ.
Atherosclerosis. 2011 Dec;219(2):690-3. Epub 2011 Aug 31.
A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene.
Tada H, Kawashiri MA, Ohtani R, Noguchi T, Nakanishi C, Konno T, Hayashi K, Nohara A, Inazu A, Kobayashi J, Mabuchi H, Yamagishi M.
Atherosclerosis. 2011 Dec;219(2):663-6. Epub 2011 Aug 10.
Where does the interplay between cholesterol absorption and synthesis in the context of statin and/or ezetimibe treatment stand today?
Descamps OS, De Sutter J, Guillaume M, Missault L.
Atherosclerosis. 2011 Aug;217(2):308-21. Epub 2011 Jun 12. Review.
Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI.
Peters BJ, Pett H, Klungel OH, Stricker BH, Psaty BM, Glazer NL, Wiggins KL, Bis JC, de Boer A, Maitland-van der Zee AH.
Atherosclerosis. 2011 Aug;217(2):458-64. Epub 2011 Jun 17.
SR-PSOX at sites predisposed to atherosclerotic lesion formation mediates monocyte-endothelial cell adhesion.
Hofnagel O, Engel T, Severs NJ, Robenek H, Buers I.
Atherosclerosis. 2011 Aug;217(2):371-8. Epub 2011 May 5.
Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction.
Yunoki K, Nakamura K, Miyoshi T, Enko K, Kohno K, Morita H, Kusano KF, Ito H.
Atherosclerosis. 2011 Aug;217(2):486-91. Epub 2011 Apr 22.
Reduced penetrance of autosomal dominant hypercholesterolemia in a high percentage of families: importance of genetic testing in the entire family.
Garcia-Garcia AB, Ivorra C, Martinez-Hervas S, Blesa S, Fuentes MJ, Puig O, Martín-de-Llano JJ, Carmena R, Real JT, Chaves FJ.
Atherosclerosis. 2011 Oct;218(2):423-30. Epub 2011 Jul 30.
The Fcγ receptor IIA R131H gene polymorphism is associated with endothelial function in patients with hypercholesterolaemia.
Schneider MP, Leusen JH, Herrmann M, Garlichs CD, Amann K, John S, Schmieder RE.
Atherosclerosis. 2011 Oct;218(2):411-5. Epub 2011 Jul 20.
Voluntary wheel running increases bile acid as well as cholesterol excretion and decreases atherosclerosis in hypercholesterolemic mice.
Meissner M, Lombardo E, Havinga R, Tietge UJ, Kuipers F, Groen AK.
Atherosclerosis. 2011 Oct;218(2):323-9. Epub 2011 Jul 12.
Humanin preserves endothelial function and prevents atherosclerotic plaque progression in hypercholesterolemic ApoE deficient mice.
Oh YK, Bachar AR, Zacharias DG, Kim SG, Wan J, Cobb LJ, Lerman LO, Cohen P, Lerman A.
Atherosclerosis. 2011 Nov;219(1):65-73. Epub 2011 Jun 25.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on